Logo
x

Search category

Subscribe Now

IgG-mediated rare diseases

Alexion to Acquire Syntimmune for antibody therapeutics targeting the neonatal Fc receptor (FcRn)

Alexion to Acquire Syntimmune for antibody therapeutics targeting the neonatal Fc receptor (FcRn)

  • September 27, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.